Search Results - "Ceuppens, Jan L."

Refine Results
  1. 1
  2. 2
  3. 3

    IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? by Bullens, Dominique M A, Truyen, Els, Coteur, Liesbeth, Dilissen, Ellen, Hellings, Peter W, Dupont, Lieven J, Ceuppens, Jan L

    Published in Respiratory research (03-11-2006)
    “…The role of Th2 cells (producing interleukin (IL-)4, IL-5 and IL-13) in allergic asthma is well-defined. A distinct proinflammatory T cell lineage has recently…”
    Get full text
    Journal Article
  4. 4

    Probiotics against airway allergy: host factors to consider by Spacova, Irina, Ceuppens, Jan L, Seys, Sven F, Petrova, Mariya I, Lebeer, Sarah

    Published in Disease models & mechanisms (01-07-2018)
    “…The worldwide prevalence of allergic diseases has drastically increased in the past decades. Recent studies underline the importance of microbial exposure for…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab by Li, Zhe, Arijs, Ingrid, De Hertogh, Gert, Vermeire, Séverine, Noman, Maja, Bullens, Dominique, Coorevits, Lieve, Sagaert, Xavier, Schuit, Frans, Rutgeerts, Paul, Ceuppens, Jan L., Van Assche, Gert

    Published in Inflammatory bowel diseases (01-08-2010)
    “…Background: Immune therapies may act in inflammatory bowel diseases (IBD) by modulating regulatory T cells (Tregs). Therefore, we investigated the effect of…”
    Get full text
    Journal Article
  8. 8

    Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease by Verstockt, Bram, Perrier, Clémentine, De Hertogh, Gert, Cremer, Jonathan, Creyns, Brecht, Van Assche, Gert, Ferrante, Marc, Ceuppens, Jan L, Vermeire, Séverine, Breynaert, Christine

    Published in Frontiers in immunology (18-12-2018)
    “…Mucosal IL-13 Receptor alpha 2 ( ) mRNA expression is one of the best predictive markers for primary non-responsiveness to infliximab therapy in patients with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease by Suenaert, Peter, Bulteel, Veerle, Lemmens, Liesbeth, Noman, Maja, Geypens, Benny, Van Assche, Gert, Geboes, Karel, Ceuppens, Jan L, Rutgeerts, Paul

    Published in The American journal of gastroenterology (01-08-2002)
    “…A primary defect of the tight junctions and, hence, increased intestinal epithelial permeability has been proposed as a basic pathogenic event in Crohn's…”
    Get full text
    Journal Article
  12. 12

    Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases by Li, Zhe, Vermeire, Séverine, Bullens, Dominique, Ferrante, Marc, Van Steen, Kristel, Noman, Maja, Bossuyt, Xavier, Rutgeerts, Paul, Ceuppens, Jan L, Van Assche, Gert

    Published in Inflammatory bowel diseases (01-12-2015)
    “…Anti-tumor necrosis factor (TNF) therapy has become a standard therapy for severe inflammatory bowel diseases (IBD), but its effect on B lymphocytes is largely…”
    Get full text
    Journal Article Web Resource
  13. 13

    Haptoglobin deficiency facilitates the development of autoimmune inflammation by Galicia, Georgina, Maes, Wim, Verbinnen, Bert, Kasran, Ahmad, Bullens, Dominique, Arredouani, Mohamed, Ceuppens, Jan L

    Published in European journal of immunology (01-12-2009)
    “…Haptoglobin (HP) is an acute phase protein synthesized by liver cells in response to IL-6. HP has been demonstrated to modulate the immune response and to have…”
    Get full text
    Journal Article
  14. 14

    Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells by Creyns, Brecht, Cremer, Jonathan, De Hertogh, Gert, Boon, Louis, Ferrante, Marc, Vermeire, Séverine, Van Assche, Gert, Ceuppens, Jan L., Breynaert, Christine

    Published in Immunity, Inflammation and Disease (01-09-2020)
    “…Introduction Insight in the pathogenesis of intestinal fibrosis is an unmet medical need in inflammatory bowel diseases. Studies in murine models and human…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Haptoglobin dampens endotoxin‐induced inflammatory effects both in vitro and in vivo by Arredouani, Mohamed S., Kasran, Ahmad, Vanoirbeek, Jeroen A., Berger, Frank G., Baumann, Heinz, Ceuppens, Jan L.

    Published in Immunology (01-02-2005)
    “…Summary We report that haptoglobin, an acute‐phase protein produced by liver cells in response to interleukin‐6 (IL‐6), can modulate the inflammatory response…”
    Get full text
    Journal Article
  17. 17

    Impact of luxS and Suppressor Mutations on the Gastrointestinal Transit of Lactobacillus rhamnosus GG by Lebeer, Sarah, Claes, Ingmar J.J, Verhoeven, Tine L.A, Shen, Chong, Lambrichts, Ivo, Ceuppens, Jan L, Vanderleyden, Jos, De Keersmaecker, Sigrid C.J

    Published in Applied and Environmental Microbiology (01-08-2008)
    “…It is generally believed that probiotic bacteria need to survive gastrointestinal transit to exert a health-promoting effect. In this study, a genuine luxS…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    IL-12 Contributes to Allergen-Induced Airway Inflammation in Experimental Asthma by Meyts, Isabelle, Hellings, Peter W, Hens, Greet, Vanaudenaerde, Bart M, Verbinnen, Bert, Heremans, Hubertine, Matthys, Patrick, Bullens, Dominique M, Overbergh, Lut, Mathieu, Chantal, De Boeck, Kris, Ceuppens, Jan L

    Published in Journal of Immunology (01-11-2006)
    “…Lack of sufficient IL-12 production has been suggested to be one of the basic underlying mechanisms in atopy, but a potential role of IL-12 in established…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Explorative study on patient's perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis by Hellings, Peter W, Dobbels, Fabienne, Denhaerynck, Kris, Piessens, Mark, Ceuppens, Jan L, De Geest, Sabina

    Published in Clinical and translational allergy (29-05-2012)
    “…Background In spite of the high prevalence of allergic rhinitis (AR) and the evidence‐based guidelines for treatment, little is known about the patients’…”
    Get full text
    Journal Article